Your browser doesn't support javascript.
loading
Efficacy and Safety of TACE Combined With Lenvatinib Plus PD-1 Inhibitors Compared With TACE Alone for Unresectable Hepatocellular Carcinoma Patients: A Prospective Cohort Study.
Qu, Shuping; Zhang, Xiaobing; Wu, Yutian; Meng, Yan; Pan, Hongyu; Fang, Qiang; Hu, Lei; Zhang, Jin; Wang, Ruoyu; Wei, Lixin; Wu, Dong.
Afiliação
  • Qu S; Department of Hepatic Surgery, Third Affiliated Hospital of Second Military Medical University, Shanghai, China.
  • Zhang X; Department of Hepatic Surgery, Third Affiliated Hospital of Second Military Medical University, Shanghai, China.
  • Wu Y; Department of Hepatic Surgery, The First Hospital of Putian, Putian, China.
  • Meng Y; Tumor Immunology and Gene Therapy Center, Third Affiliated Hospital of Second Military Medical University, Shanghai, China.
  • Pan H; Department of Hepatic Surgery, Third Affiliated Hospital of Second Military Medical University, Shanghai, China.
  • Fang Q; Department of Hepatic Surgery, Third Affiliated Hospital of Second Military Medical University, Shanghai, China.
  • Hu L; Department of Hepatic Surgery, Third Affiliated Hospital of Second Military Medical University, Shanghai, China.
  • Zhang J; Department of Hepatic Surgery, Third Affiliated Hospital of Second Military Medical University, Shanghai, China.
  • Wang R; Department of Hepatic Surgery, Third Affiliated Hospital of Second Military Medical University, Shanghai, China.
  • Wei L; Tumor Immunology and Gene Therapy Center, Third Affiliated Hospital of Second Military Medical University, Shanghai, China.
  • Wu D; Department of Hepatic Surgery, Third Affiliated Hospital of Second Military Medical University, Shanghai, China.
Front Oncol ; 12: 874473, 2022.
Article em En | MEDLINE | ID: mdl-35530353
Palavras-chave
Texto completo
Adicionar na Minha BVS
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Tipo de estudo: Etiology_studies / Observational_studies / Prognostic_studies / Risk_factors_studies Idioma: En Revista: Front Oncol Ano de publicação: 2022 Tipo de documento: Article País de afiliação: China País de publicação: Suíça
Texto completo
Adicionar na Minha BVS
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Tipo de estudo: Etiology_studies / Observational_studies / Prognostic_studies / Risk_factors_studies Idioma: En Revista: Front Oncol Ano de publicação: 2022 Tipo de documento: Article País de afiliação: China País de publicação: Suíça